Exclusive: CureVac becomes second company to test coronavirus vaccine in Germany – sources

  • Current Events
  • Exclusive: CureVac becomes second company to test coronavirus vaccine in Germany – sources

FRANKFURT (Reuters) – The unlisted biotech firm CureVac will become the second company to launch human trials of an experimental coronavirus vaccine in Germany, two people familiar with the plans told Reuters on Tuesday.

The clinical trial, to be announced on Wednesday, is the second to be approved by Germany’s vaccines regulator, the Paul Ehrlich Institute, after a trial by BioNTech that began in April.

CureVac and the Paul Ehrlich Institute declined to comment.

The World Health Organization lists 11 experimental coronavirus vaccines as currently being tested on humans, according to a table posted on its website.

The German government on Monday unveiled a deal to take an agreed 23% stake in CureVac for a cash injection of 300 million euros ($338 million).

Later that day, a finance ministry document seen by Reuters showed that the firm – controlled by SAP co-founder Dietmar Hopp – plans an initial public offering in the United States next month.

Germany and partner countries in the European Union last week pledged funds for the production of an experimental vaccine being developed by the University of Oxford and AstraZeneca, saying they needed to spread their bets across several more candidates.

Britain and the United States had previously made commitments to secure hundreds of millions of doses of the AstraZeneca vaccine, which is based on so-called viral vector technology, as developers across the world prepare to produce even before their candidates are shown to work in trials.

Media reports in March that the United States had tried to gain access to CureVac or its vaccine stirred a political backlash in Germany, where members of the government called for it to remain German-owned.

CureVac’s management has denied receiving offers from the United States.

The company, which is based in Tuebingen and backed by the Bill & Melinda Gates Foundation, is using the so-called messenger RNA approach, like BioNTech and its partner Pfizer as well as Moderna.

Translate Bio and its partner Sanofi are also working on a messenger RNA vaccine against the coronavirus.

Reporting by Ludwig Burger and Patricia Weiss; Editing by Kevin Liffey

Our Standards:The Thomson Reuters Trust Principles.

Did you like this article? You can read it and many others @ Reuters!

FRESHEST

Here's the latest news

María Belén Pérez Maurice got the surprise of a lifetime at the 2020 Tokyo Olympics. The 36-year-old Argentinian fencer was speaking to the press after her loss against Hungarian athlete Anna Márton when her coach and boyfriend of 17 years, Lucas...

Fencer’s Coach Surprises Her With On-Camera Proposal at Olympics

WASHINGTON — The Department of Veterans Affairs will require 115,000 of its frontline health care workers to be vaccinated against the coronavirus in the next two months, making it the first federal agency to mandate that employees be inoculated, government...

V.A. Issues Vaccine Mandate for Health Care Workers, a First for a Federal Agency

The NBA playoffs have concluded, but as the saying goes, basketball never stops. NBA Draft season has arrived. This year's draft class is strong at the top with potentially franchise-changing prospects such as Oklahoma State's Cade Cunningham and USC's Evan...

When is the NBA Draft in 2021? Date, time, location, pick order & more to know

If you want people to trust the photos and videos your business puts out, it might be time to start learning how to prove they haven't been tampered with. Image: Lightspring/Shutterstock Great (or terrifying) moments in deepfake history: The argument...

Deepfakes: Microsoft and others in Big Tech are working to bring authenticity to videos, photos

"Wait, What" by Carlos Benzecri, available for sale until July 31 at CRUSH. Photography courtesy of XPOSED. CRUSH, an exhibit of Canadian art, runs until July 31. All proceeds go to Rainbow Railroad, an organization that helps LGBTQI+ individuals facing...

CRUSH Art Exhibit: Until July 31, All Proceeds Benefit Rainbow Railroad
Load More
Share via
Copy link
Powered by Social Snap